IMC:ASX
Immuron Ltd
၀.၀၃၇ A$
၀.၀၀%
(၀.၀၀) 1D
နို ၁၂, GMT+၁၁ ၁၂:၁၂:၀၀ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IMC...
Mkt. cap
၁.၁၉ ကုဋေ
Avg. vol.
၁.၁၂ သိန်း
Volume
၀.၀၀
52-wk high
၀.၀၇ A$
52-wk low
၀.၀၃ A$
EPS
-၀.၀၁ A$
Shares outstanding
၃၂.၂၈ ကုဋေ
No. of employees
၈
Mkt. cap
၁.၁၉ ကုဋေ
Avg. vol.
၁.၁၂ သိန်း
Volume
၀.၀၀
52-wk high
၀.၀၇ A$
52-wk low
၀.၀၃ A$
EPS
-၀.၀၁ A$
Shares outstanding
၃၂.၂၈ ကုဋေ
No. of employees
၈
News stories
From web sources and news partners
Los Angeles Times
·
ပြီးခဲ့သည့် ၁၂ မိနစ်
A fifth straight drop for the S&P 500 drags Wall Street to its longest losing streak since June
Barron's
·
ပြီးခဲ့သည့် ၁ နာရီ
Generac Jolted After Nvidia Earnings. Why It’s a Top S&P 500 Stock Today.
BigGo Finance
·
ပြီးခဲ့သည့် ၂ နာရီ
S&P 500's Shiller P/E Tops 40 Again, Echoing Dot-Com Era Valuations
Traders Union
·
ပြီးခဲ့သည့် ၂ နာရီ
S&P 500 movement in 1992–2010 often tied to valuation multiples, Brett Caughran notes
Profile
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
About Immuron Ltd
CEO-
Employees၈
Founded၁၉၉၄
HeadquartersBlackburn North, ဝိတိုရိယ ပြည်နယ်, ဩစတြေးလျ
SectorHealth Care
Industry-
Websiteimmuron.com.au